Comparison of standard-dose and halfdose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysis

Publisher： Spandidos Publications

E-ISSN： 1791-2423|45|6|2295-2302

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.45, Iss.6, 2014-01, pp. : 2295-2302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: Propensity score matching analysis

By                      

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 1082-1090

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1214-1223

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report

By Wang Sean  

Targeted Oncology, Vol. 5, Iss. 1, 2010-03 ,pp. : 59-63

Springer Publishing Company

Access to resources Recommend Favorite

Complete regression following sorafenib in unresectable, locally advanced hepatocellular carcinoma

By Moroni Marco   Zanlorenzi Laura  

Future Oncology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1231-1237

Future Medicine

Access to resources Recommend Favorite

Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice

By Kudo Masatoshi  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 242-255

Springer Publishing Company

Access to resources Recommend Favorite